SCHEMBL1356602

SCHEMBL1356602

COC1([O])CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1358350 0.97
SCHEMBL28564067 0.93
SCHEMBL23300641 0.86
SCHEMBL11872689 0.77
SCHEMBL8716314 0.73
SCHEMBL17593536 0.68
SCHEMBL11198454 0.67
SCHEMBL7069430 0.65 SMN1; SMN2 (0.31)
SCHEMBL28878169 0.65
SCHEMBL731782 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230012600-A1 BRIDGED CYCLOFORMYLPYRIDINE DERIVATIVES AND USES THEREOF BROADENBIO CO., LTD. (CN) 2023-01-19 US disclosed
CN-114650991-A Bridged ring-fused aldehyde pyridine derivative and application thereof 北京伯汇生物技术有限公司 2022-06-21 CN disclosed
CN-114488688-A Liquid crystal display element, method for producing same, and radiation-sensitive resin composition JSR株式会社 2022-05-13 CN disclosed
CN-112759593-A Bridged ring-fused aldehyde pyridine derivative and application thereof 北京伯汇生物技术有限公司 2021-05-07 CN disclosed
US-10273242-B2 Compound inhibiting activities of BTK and/or JAK3 kinases Beijing Hanmi Pharmaceutical Co., Ltd. (CN) 2019-04-30 US disclosed
US-20180051036-A1 COMPOUND INHIBITING ACTIVITIES OF BTK AND/OR JAK3 KINASES Beijing Hanmi Pharmaceutical Co., Ltd. (CN) 2018-02-22 US disclosed
US-9840517-B2 Compound inhibiting activities of BTK and/or JAK3 kinases Beijing Hanmi Pharmaceutical Co., Ltd. (CN) 2017-12-12 US disclosed
US-20160229865-A1 COMPOUND INHIBITING ACTIVITIES OF BTK AND/OR JAK3 KINASES Beijing Hanmi Pharmaceutical Co., Ltd. (CN) 2016-08-11 US disclosed
EP-3048105-A1 COMPOUND INHIBITING ACTIVITIES OF BTK AND/OR JAK3 KINASES Beijing Hanmi Pharmaceutical Co., Ltd. (CN) 2016-07-27 EP disclosed
CN-102870047-B Positive radiation-sensitive composition, display element interlayer dielectric and forming method thereof JSR CORP. (JP) 2016-03-02 CN disclosed
US-6723715-B1 HORMONE REPLACEMENT THERAPY; FERTILITY AGENTS SCHERING AG (DE) 2004-04-20 US disclosed
US-6710039-B1 HORMONE RELATED DISEASES, FERTILITY CONTROL SCHERING AG (DE) 2004-03-23 US disclosed
EP-1242445-B1 14,15-CYCLOPROPANOSTEROIDS OF THE 19-NORANDROSTANE SERIES, METHOD FOR PRODUCING SAID COMPOUNDS AND PHARMACEUTICAL PREPARATION CONTAINING SAID COMPOUNDS SCHERING AG (DE) 2003-04-23 EP disclosed
EP-1242445-A1 14,15-CYCLOPROPANOSTEROIDS OF THE 19-NORANDROSTANE SERIES, METHOD FOR PRODUCING SAID COMPOUNDS AND PHARMACEUTICAL PREPARATION CONTAINING SAID COMPOUNDS Jenapharm GmbH &amp; Co. KG (DE) 2002-09-25 EP disclosed
WO-2001042274-A1 14,15-CYCLOPROPANOSTEROIDS OF THE 19-NORANDROSTANE SERIES, METHOD FOR PRODUCING SAID COMPOUNDS AND PHARMACEUTICAL PREPARATION CONTAINING SAID COMPOUNDS JENAPHARM GMBH & CO. KG (DE) 2001-06-14 WO disclosed
EP-0793144-B1 Radiation sensitive composition JAPAN SYNTHETIC RUBBER CO LTD (JP) 2001-01-17 EP disclosed
US-5962180-A COMPRISING (A) A COPOLYMER COMPRISING RECURRING UNITS OF A P-HYDROXYSTYRENE UNIT AND A STYRENE UNIT HAVING AN ACETAL GROUP OR A KETAL GROUP AT THE P-POSITION, (B) A COPOLYMER COMPRISING RECURRING UNITS OF A T-BUTYL (METH)ACRYLATE UNIT JSR CORPORATION (JP) 1999-10-05 US disclosed
EP-0793144-A2 Radiation sensitive composition JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1997-09-03 EP disclosed
US-5573999-A FUNGICIDES AND INSECTICIDES BASF AKTIENGESELLSCHAFT (DE) 1996-11-12 US disclosed
WO-1996030023-A1 19-OXYGENATED STEROIDS AS THERAPEUTIC AGENTS PETROW VLADIMIR (US) 1996-10-03 WO disclosed